How many times has a patient said, "Oh, by the way, doctor..." just as you're leaving the exam room? This column will help you quickly triage those seemingly offhand yet clinically significant encounters.
Andrew Berchuck, MD
Advertisement
DR. BERCHUCK is F. Bayard Carter Distinguished Professor of Obstetrics and Gynecology in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, N.C., and a member of the Contemporary OB/GYN E
Articles by Andrew Berchuck, MD
Will biological warfare revolutionize the battle against gynecologic cancers? Two experts share the latest molecular tactics using "special" agents. Lethal weapons like Herceptin can throw up some roadblocks, even when they can't always destroy a tumor.
Will biological warfare revolutionize the battle against gynecologic cancers? Two experts share the latest molecular tactics using "special" agents. Lethal weapons like Herceptin can throw up some roadblocks, even when they can't always destroy a tumor.
Advertisement
Latest Updated Articles
- Sign Out: Destiny's child
Published: October 1st 2004 | Updated:
- Targeted bio weapons in the war against gynecologic cancers
Published: October 1st 2006 | Updated:
- Targeted bio weapons in the war against gynecologic cancers
Published: October 1st 2006 | Updated:
- Oh, by the way. . . what about this mole?
Published: November 1st 2006 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN week in review: birth complications, fasting, and more
2
Eve Zaritsky, MD, highlights improved oral contraceptive access from e-visits
3
Survey reveals misconceptions about pregnancy safety for older women
4
Bibiana Avella Molano, MD, links rural residence to birth complication risk
5
